Figures
There is an error in Table 1. An AspTyr mutation is wrongly abbreviated as D516T (1). It should be listed as D516Y (1). Please see the corrected Table 1 here.
Table 1. MICs and relative resistance of rifampicin and rifabutin in M. tuberculosis.
Reference
Citation: Sirgel FA, Warren RM, Böttger EC, Klopper M, Victor TC, van Helden PD (2015) Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. PLoS ONE 10(7): e0134190. https://doi.org/10.1371/journal.pone.0134190
Published: July 21, 2015
Copyright: © 2015 Sirgel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited